{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:50:32Z","timestamp":1772895032249,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/ajkd.2001.27380","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T23:33:20Z","timestamp":1205796800000},"page":"S4-S7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"S","title":["Paradox of risk factors for cardiovascular mortality in uremia: Is a higher cholesterol level better for atherosclerosis in uremia?"],"prefix":"10.1053","volume":"38","author":[{"given":"Yoshiki","family":"Nishizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2001.27380_BIB1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM197403282901301","article-title":"Accelerated atherosclerosis in prolonged maintenance hemodialysis","volume":"290","author":"Lindner","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2001.27380_BIB2","first-page":"S84","article-title":"Should hyperlipemia of renal failure be treated?","volume":"17","author":"Ritz","year":"1985","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/ajkd.2001.27380_BIB3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000182627","article-title":"Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study","volume":"31","author":"Degoulet","year":"1982","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2001.27380_BIB4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0091-7435(91)90061-8","article-title":"Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group","volume":"20","author":"Shaten","year":"1991","journal-title":"Prev Med"},{"key":"10.1053\/ajkd.2001.27380_BIB5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.1995.356","article-title":"High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia","volume":"48","author":"Kawagishi","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2001.27380_BIB6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9150(00)00529-3","article-title":"Additive impacts of diabetes and renal failure on carotid atherosclerosis","volume":"153","author":"Shoji","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1053\/ajkd.2001.27380_BIB7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.V971277","article-title":"Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients","volume":"9","author":"Shoji","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 1","key":"10.1053\/ajkd.2001.27380_BIB8","first-page":"S665A","article-title":"Relationship between carotid atherosclerosis and prognosis in hemodialysis patients","volume":"32","author":"Nagasue","year":"1999","journal-title":"J Jpn Soc Dial Ther"},{"key":"10.1053\/ajkd.2001.27380_BIB9","unstructured":"T Shoji, M Emoto, K Shinohara, R Kakiya, Y Tsujimoto, H Kishimoto, E Ishimura, T Tabata, Y Nishizawa, Diabetes, aortic stiffness and cardiovascular mortality in end-stage renal disease, J Am Soc Nephrol ((in press))."},{"key":"10.1053\/ajkd.2001.27380_BIB10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/ajkd.2000.17676","article-title":"Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group","volume":"36","author":"Iseki","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2001.27380_BIB11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/ndt\/15.11.1808","article-title":"Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group","volume":"15","author":"Iseki","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2001.27380_BIB12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.V8121889","article-title":"Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients","volume":"8","author":"Koch","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2001.27380_BIB13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.86.2.475","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients","volume":"86","author":"Cressman","year":"1992","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2001.27380_BIB14","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s001250050825","article-title":"Cardiac disease in diabetic end-stage renal disease","volume":"40","author":"Foley","year":"1997","journal-title":"Diabetologia"},{"key":"10.1053\/ajkd.2001.27380_BIB15","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.ATV.17.11.2554","article-title":"Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study","volume":"17","author":"Bostom","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/ajkd.2001.27380_BIB16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2001.27380_BIB17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2001.27380_BIB18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1046\/j.1523-1755.2000.00018.x","article-title":"Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients","volume":"57","author":"Suliman","year":"2000","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860157496X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860157496X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:23:30Z","timestamp":1759454610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263860157496X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S027263860157496X"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2001.27380","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradox of risk factors for cardiovascular mortality in uremia: Is a higher cholesterol level better for atherosclerosis in uremia?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2001.27380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}